Humacyte, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Humacyte, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q3 2024.
- Humacyte, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$8.97M, a 553% decline year-over-year.
- Humacyte, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$40.4M, a 867% decline year-over-year.
- Humacyte, Inc. annual Nonoperating Income (Expense) for 2023 was -$10.7M, a 115% decline from 2022.
- Humacyte, Inc. annual Nonoperating Income (Expense) for 2022 was $72.6M, a 32.7% increase from 2021.
- Humacyte, Inc. annual Nonoperating Income (Expense) for 2021 was $54.7M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)